Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmaron Beijing Co., Ltd. Class H ( (HK:3759) ) just unveiled an announcement.
Pharmaron Beijing Co., Ltd. has established an Audit Committee under its Board of Directors to enhance corporate governance and ensure effective oversight of senior management. The committee, composed of independent non-executive directors, will oversee the company’s financial disclosures and audit processes, thereby strengthening decision-making and internal controls.
The most recent analyst rating on (HK:3759) stock is a Buy with a HK$28.10 price target. To see the full list of analyst forecasts on Pharmaron Beijing Co., Ltd. Class H stock, see the HK:3759 Stock Forecast page.
More about Pharmaron Beijing Co., Ltd. Class H
Pharmaron Beijing Co., Ltd. operates within the pharmaceutical industry, focusing on providing research and development services. The company is known for its comprehensive offerings that span the entire drug discovery and development process, catering to a global market.
Average Trading Volume: 13,234,723
Technical Sentiment Signal: Buy
Current Market Cap: HK$59.02B
See more data about 3759 stock on TipRanks’ Stock Analysis page.